Literature DB >> 21377501

Exogenous ghrelin attenuates endotoxin fever in rats.

Renato N Soriano1, Lelis G Nicoli, Evelin C Carnio, Luiz G S Branco.   

Abstract

Ghrelin is a gut-derived peptide that plays a role in energy homeostasis. Recent studies have implicated ghrelin in systemic inflammation, showing increased plasma ghrelin levels after endotoxin (lipopolysaccharide, LPS) administration. The aims of this study were (1) to test the hypothesis that ghrelin administration affects LPS-induced fever; and (2) to assess the putative effects of ghrelin on plasma corticosterone secretion and preoptic region prostaglandin (PG) E(2) levels in euthermic and febrile rats. Rats were implanted with a temperature datalogger capsule in the peritoneal cavity to record body core temperature. One week later, they were challenged with LPS (50 μg/kg, intraperitoneal, i.p.) alone or combined with ghrelin (0.1mg/kg, i.p.). In another group of rats, plasma corticosterone and preoptic region PGE(2) levels were measured 2h after injections. In euthermic animals, systemic administration of ghrelin failed to elicit any thermoregulatory effect, and caused no significant changes in basal plasma corticosterone and preoptic region PGE(2) levels. LPS caused a typical febrile response, accompanied by increased plasma corticosterone and preoptic PGE(2) levels. When LPS administration was combined with ghrelin fever was attenuated, corticosterone secretion further increased, and the elevated preoptic PGE(2) levels were relatively reduced, but a correlation between these two variables (corticosterone and PGE(2)) failed to exist. The present data add ghrelin to the neurochemical milieu controlling the immune/thermoregulatory system acting as an antipyretic molecule. Moreover, our findings also support the notion that ghrelin attenuates fever by means of a direct effect of the peptide reducing PGE(2) production in the preoptic region.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21377501     DOI: 10.1016/j.peptides.2011.02.019

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  4 in total

1.  Impact of synthetic ghrelin administration for patients with severe body weight reduction more than 1 year after gastrectomy: a phase II clinical trial.

Authors:  Shuji Takiguchi; Yasuhiro Miyazaki; Tsuyoshi Takahashi; Yukinori Kurokawa; Makoto Yamasaki; Kiyokazu Nakajima; Hiroshi Miyata; Hiroshi Hosoda; Kenji Kangawa; Masaki Mori; Yuichiro Doki
Journal:  Surg Today       Date:  2015-05-29       Impact factor: 2.549

2.  Sickness behaviour after lipopolysaccharide treatment in ghrelin deficient mice.

Authors:  Éva Szentirmai; James M Krueger
Journal:  Brain Behav Immun       Date:  2013-12-03       Impact factor: 7.217

3.  Severely obese adolescents and adults exhibit a different association of circulating levels of adipokines and leukocyte expression of the related receptors with insulin resistance.

Authors:  Antonello E Rigamonti; Fiorenza Agosti; Alessandra De Col; Giancarlo Silvestri; Nicoletta Marazzi; Silvia Bini; Sara Bonomo; Marialuisa Giunta; Silvano G Cella; Alessandro Sartorio
Journal:  Int J Endocrinol       Date:  2013-12-21       Impact factor: 3.257

4.  Effects of ghrelin supplementation on the acute phase of Chagas disease in rats.

Authors:  Ferdinando de Paula Silva; Cássia Mariana Bronzon da Costa; Luiz Miguel Pereira; Diego Fernando Silva Lessa; Dimitrius Leonardo Pitol; João Paulo Mardegan Issa; José Clóvis do Prado Júnior; Ana Amélia Carraro Abrahão
Journal:  Parasit Vectors       Date:  2019-11-09       Impact factor: 3.876

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.